Latanoprost Completed Phase 2 Trials for Glaucoma, Primary Open Angle (POAG) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01887223Transconjunctival Needling Revision Versus Medical Treatment
NCT01494753Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension